Venus Remedies

Part of MojoOne Strategy

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE411B01019
NSEID: VENUSREM
BSEID: 526953
View on NSE | View on BSE

INR

1,547.55

-14.85 (-0.95%)

BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 37.22 k

Access older stock analysis version

{
  "main_header": {
    "sid": 568580,
    "name": "Venus Remedies",
    "stock_name": "Venus Remedies",
    "full_name": "Venus Remedies Ltd",
    "name_url": "stocks-analysis/venus-remedies",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,547.55",
    "chg": -14.85,
    "chgp": "-0.95%",
    "dir": -1,
    "prev_price": "1,562.40",
    "mcapval": "2,065.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526953,
    "symbol": "VENUSREM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE411B01019",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "21:40 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "37.22 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venus-remedies-568580-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venus-remedies-568580-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Venus Remedies Ltd Declines 1.22% Amid Valuation Upgrade and Mixed Weekly Moves",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-declines-122-amid-valuation-upgrade-and-mixed-weekly-moves-4143577",
        "imagepath": "",
        "date": "2026-08-08 17:01:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> Stock opens strong at Rs.1,594.60 (+1.79%) amid positive market sentiment</p>\n                    <p><strong>4 Aug:</strong> Sharp decline to Rs.1,542.15 (-3.29%) following profit booking</p>\n                    <p><strong>6 Aug:</strong> Upgrade to Buy rating by MarketsMOJO announced; stock rebounds to Rs.1,562.40 (+2.55%)</p>\n                    <p><strong>7 Aug:</strong> Minor correction to Rs.1,547.55 (-0.95%) closes the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,566.60</div></div>\n                    <div class=\"stat-item..."
      },
      {
        "title": "Venus Remedies Ltd Upgraded to Buy on Strong Valuation and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/venus-remedies-ltd-upgraded-to-buy-on-strong-valuation-and-financial-performance-4139362",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VenusRemediesLt_mojoScore_4139362.png",
        "date": "2026-08-06 08:23:16",
        "description": "Venus Remedies Ltd has seen its investment rating upgraded from Hold to Buy, driven primarily by an improved valuation profile and robust financial performance. The company’s micro-cap status, combined with strong operational metrics and technical signals, underpins this positive reassessment by MarketsMOJO as of 5 August 2026."
      },
      {
        "title": "Venus Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-valuation-shifts-signal-renewed-price-attractiveness-4139036",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/VenusRemediesLt_valuationdot_4139036.png",
        "date": "2026-08-06 08:01:02",
        "description": "Venus Remedies Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, supported by robust financial metrics and a compelling growth trajectory. This micro-cap pharmaceutical player now presents a more enticing price proposition relative to its historical averages and peer group, signalling renewed investor interest and potential upside."
      },
      {
        "title": "Venus Remedies Ltd Falls 5.09%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-falls-509-3-key-factors-driving-the-weekly-decline-4131883",
        "imagepath": "",
        "date": "2026-08-01 17:01:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock closes sharply lower at Rs.1,569.35 (-4.92%) following downgrade</p>\n                    <p><strong>28 Jul:</strong> Venus Remedies hits lower circuit amid intense selling pressure</p>\n                    <p><strong>28 Jul:</strong> Technical momentum shifts from bullish to mildly bullish</p>\n                    <p><strong>31 Jul:</strong> Week closes at Rs.1,566.60 (-0.31% on day)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,650.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div>..."
      },
      {
        "title": "Venus Remedies Ltd Locks at Lower Circuit With 3.99% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4124297",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VenusRemediesLt_stocks_hitting_lower_circuit_4124297.png",
        "date": "2026-07-28 11:00:09",
        "description": "At Rs 1,509.3, sellers were still queuing — but there were no buyers willing to take the other side. Venus Remedies Ltd locked at its lower circuit of 3.99% on 28 Jul 2026, with unfilled sell orders and a frozen price that capped losses for the day."
      },
      {
        "title": "Venus Remedies Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/venus-remedies-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4123655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VenusRemediesLt_mojoScore_4123655.png",
        "date": "2026-07-28 08:44:04",
        "description": "Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 27 July 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite robust financial performance and impressive long-term returns, evolving market dynamics and technical signals have prompted a more cautious stance."
      },
      {
        "title": "Venus Remedies Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-4123296",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VenusRemediesLt_technicaldot_4123296.png",
        "date": "2026-07-28 08:02:38",
        "description": "Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a sharp decline in its share price over the past month, the stock’s long-term returns remain impressive, though recent technical indicators suggest a more cautious outlook for investors."
      },
      {
        "title": "Venus Remedies Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/venus-remedies-ltd-is-rated-buy-4121064",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/VenusRemediesLt_mojoScore_4121064.png",
        "date": "2026-07-26 10:10:29",
        "description": "Venus Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 14 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Venus Remedies Ltd Falls 8.63%: 6 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-ltd-falls-863-6-key-factors-driving-the-weeks-volatility-4120977",
        "imagepath": "",
        "date": "2026-07-26 10:02:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>20 Jul:</strong> Stock hits lower circuit amid heavy selling pressure</p>\n                    <p><strong>21 Jul:</strong> Upper circuit hit following strong Q1 FY27 results</p>\n                    <p><strong>22 Jul:</strong> Plunges again to lower circuit despite sector stability</p>\n                    <p><strong>24 Jul:</strong> Ends week with another lower circuit hit, closing at Rs.1,650.60</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,806.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..."
      }
    ],
    "total": 499,
    "sid": "568580",
    "stock_news_url": "https://www.marketsmojo.com/news/venus-remedies-568580"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Aug-2026",
      "details": "As per enclosed file.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "27-Jul-2026",
      "details": "Newspaper publication of 37th AGM Notice.",
      "source": "BSE"
    },
    {
      "caption": "Notice Of 37Th Annual General Meeting Of The Company.",
      "datetime": "24-Jul-2026",
      "details": "As per the pdf enclosed.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Venus Remedies Ltd has declared <strong>100%</strong> dividend, ex-date: 07 Aug 26",
          "dt": "2026-08-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Venus Remedies Ltd Declines 1.22% Amid Valuation Upgrade and Mixed Weekly Moves

2026-08-08 17:01:58

Key Events This Week

3 Aug: Stock opens strong at Rs.1,594.60 (+1.79%) amid positive market sentiment

4 Aug: Sharp decline to Rs.1,542.15 (-3.29%) following profit booking

6 Aug: Upgrade to Buy rating by MarketsMOJO announced; stock rebounds to Rs.1,562.40 (+2.55%)

7 Aug: Minor correction to Rs.1,547.55 (-0.95%) closes the week

Week Open

Rs.1,566.60

Read full news article

Venus Remedies Ltd Upgraded to Buy on Strong Valuation and Financial Performance

2026-08-06 08:23:16

Venus Remedies Ltd has seen its investment rating upgraded from Hold to Buy, driven primarily by an improved valuation profile and robust financial performance. The company’s micro-cap status, combined with strong operational metrics and technical signals, underpins this positive reassessment by MarketsMOJO as of 5 August 2026.

Read full news article

Venus Remedies Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-06 08:01:02

Venus Remedies Ltd has seen a notable shift in its valuation parameters, moving from a fair to an attractive rating, supported by robust financial metrics and a compelling growth trajectory. This micro-cap pharmaceutical player now presents a more enticing price proposition relative to its historical averages and peer group, signalling renewed investor interest and potential upside.

Read full news article

Venus Remedies Ltd Falls 5.09%: 3 Key Factors Driving the Weekly Decline

2026-08-01 17:01:21

Key Events This Week

27 Jul: Stock closes sharply lower at Rs.1,569.35 (-4.92%) following downgrade

28 Jul: Venus Remedies hits lower circuit amid intense selling pressure

28 Jul: Technical momentum shifts from bullish to mildly bullish

31 Jul: Week closes at Rs.1,566.60 (-0.31% on day)

Read full news article

Venus Remedies Ltd Locks at Lower Circuit With 3.99% Loss — Sellers Queue, No Buyers in Sight

2026-07-28 11:00:09

At Rs 1,509.3, sellers were still queuing — but there were no buyers willing to take the other side. Venus Remedies Ltd locked at its lower circuit of 3.99% on 28 Jul 2026, with unfilled sell orders and a frozen price that capped losses for the day.

Read full news article

Venus Remedies Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals

2026-07-28 08:44:04

Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 27 July 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technical indicators. Despite robust financial performance and impressive long-term returns, evolving market dynamics and technical signals have prompted a more cautious stance.

Read full news article

Venus Remedies Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-07-28 08:02:38

Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a sharp decline in its share price over the past month, the stock’s long-term returns remain impressive, though recent technical indicators suggest a more cautious outlook for investors.

Read full news article

Venus Remedies Ltd is Rated Buy

2026-07-26 10:10:29

Venus Remedies Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 14 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 July 2026, providing investors with the latest insights into the company’s performance and outlook.